Stay updated on Dapagliflozin in Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Respiratory Failure Clinical Trial page
- Check2 days agoChange DetectedLocation entry Saket, New Delhi, India, 110017 was added and the diacritic variant Sāket was removed, with the revision updated to v3.4.1. A government funding/status notice regarding NIH operations was added.SummaryDifference0.3%

- Check9 days agoChange DetectedShow glossary; add metadata entries like 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were renamed or removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag changed from v3.3.3 to v3.3.4, which appears to be a minor documentation update rather than a change to the study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedStudy locations were updated with many new sites across US, Argentina, Brazil, India, Canada, UK, and others, and several entries were removed; revision tag updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check52 days agoChange Detected- The location entry for New Delhi, India was corrected from 'Sāket' to 'Saket' (110017) in the study locations.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. No visible changes to study details or page functionality.SummaryDifference0.0%

Stay in the know with updates to Dapagliflozin in Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.